Apr 29, 2026 07:00AM
Apr 29, 2026 07:00AM
Apr 27, 2026 04:01PM
Apr 27, 2026 04:01PM
Mar 2, 2026 12:28PM
Feb 26, 2026 01:31PM
Feb 12, 2026 02:40PM Form SCHEDULE 13G/A Intellia Therapeutics, Filed by: GOLDMAN SACHS GROUP INC
Nov 12, 2025 03:55PM
Feb 28, 2025 07:06AM
Feb 23, 2024 09:19AM
Dec 1, 2022 07:30AM
Nov 30, 2022 09:28PM
Nov 30, 2022 04:37PM
Nov 30, 2022 04:36PM Intellia Therapeutics Announces Proposed Public Offering of Common Stock
Aug 4, 2022 04:12PM
Jul 2, 2021 04:01PM
Jun 30, 2021 05:00AM
Jun 29, 2021 09:08PM
Jun 29, 2021 09:27AM
Jun 28, 2021 06:48PM
Jun 28, 2021 04:02PM Intellia Therapeutics (NTLA) Announces $400M Proposed Offering
Jun 28, 2021 04:01PM
Jun 28, 2021 09:28AM
Jun 28, 2021 06:30AM
Jun 22, 2021 07:01AM
Jun 22, 2021 07:00AM
Dec 4, 2020 04:01PM
Dec 2, 2020 06:04AM Intellia Therapeutics (NTLA)Prices 4.795M Share Common Offering at $36.50/Sh
Dec 1, 2020 09:30PM
Dec 1, 2020 09:25AM
Nov 30, 2020 04:01PM
Nov 30, 2020 04:01PM
Sep 18, 2020 06:13AM
Jun 5, 2020 04:01PM
Jun 3, 2020 05:54AM Intellia Therapeutics (NTLA) Prices 5.48M Share Common Offering at $18.25/Sh
Jun 2, 2020 09:00PM
Jun 1, 2020 04:01PM
Jun 1, 2020 04:00PM
Oct 11, 2018 09:11AM
Mar 1, 2017 07:10AM

184,700 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All